VILNIUS, LITHUANIA / ACCESSWIRE / August 2, 2023 / As the second fastest-growing company in Europe, Kilo Health has a…
Data Presented at the Society of NeuroInterventional Surgery Annual Meeting Underscore the Utility of Company’s Zoom Access and Aspiration Portfolio…
MicroVention’s WEB System is the World Leader and Only PMA-Approved Intrasaccular Flow Disruptor; Advances Treatment of Wide-Neck Bifurcation Aneurysms with…
Grant Funds Will Support Proof-of-Concept Target Validation Studies for Preclinical Development of a Potential New Approach for the Prevention and…
Independent Data Monitoring Committee recommended REVEAL Phase 1/2 trial continuation and proceeding with dosing of second patient based on encouraging…
PALO ALTO, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180LS” or the “Company”), today…
Technology Enables Physicians to Remotely Make Pre-Diagnostic Assessment Regarding Whether an In-Person Diagnostic Examination of Ocular Anatomy is WarrantedPETALUMA, Calif.,…
Fortifeye Vitamins Releases Next Gen, Zinc-Free Macular DefenseOCALA, FL / ACCESSWIRE / July 28, 2023 / Fortifeye Vitamins, a pioneering…
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa” or the “Company”), a clinical…
Safety Review Committee clears MDNA11 Cohort 6 dose of 120µg/Kg, Q2W, in the Phase 1 portion of the ABILITY Study…